Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Biocept Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
BIOC is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023
- Institutional holders
- 11
- −15 vs. Q1 2023
- Shares held
- 80.0K
- −819.3K (−91.1%) vs. Q1 2023
- Total value
- $96.4K
- −$207.8K (−68.3%) vs. Q1 2023
- New holders
- 3
- 0 more added
- Sold out
- 18
- 8 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 13 | $218.0K |
| Q2 2023 | 11 | $96.4K |
| Q1 2023 | 26 | $304.2K |
| Q4 2022 | 26 | $807.7K |
| Q3 2022 | 29 | $1.57M |
| Q2 2022 | 29 | $1.78M |
| Q1 2022 | 30 | $4.90M |
| Q4 2021 | 35 | $8.32M |
| Q3 2021 | 29 | $8.12M |
| Q2 2021 | 24 | $6.76M |
| Q1 2021 | 25 | $7.21M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Biocept Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Anson Funds Management LP | 44,861 | $54.3K | 0.02% | +44,861 | New |
| Boothbay Fund Management, LLC | 23,529 | $28.5K | 0.00% | +23,529 | New |
| Tower Research Capital LLC (TRC) | 5,389 | $6.52K | 0.00% | −2,980−35.6% | Reduced |
| BlackRock Inc. | 5,261 | $6.37K | 0.00% | −152,652−96.7% | Reduced |
| Group One Trading, L.P. | 270 | $327 | 0.00% | −7,730−96.6% | Reduced |
| JPMorgan Chase & Co | 268 | $324 | 0.00% | +268 | New |
| Advisor Group Holdings, Inc. | 33 | $40 | 0.00% | −967−96.7% | Reduced |
| US Bancorp | 18 | $21 | 0.00% | −565−96.9% | Reduced |
| Wells Fargo & Company | 4 | $5 | 0.00% | −114−96.6% | Reduced |
| Acadian Asset Management LLC | 247 | $0 | 0.00% | −13,624−98.2% | Reduced |
| Royal Bank of Canada | 115 | $0 | 0.00% | −3,372−96.7% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −193,741−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −134,112−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −94,200−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −55,334−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −40,596−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −29,602−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −26,818−100.0% | Sold out |
| Taylor & Morgan Wealth Management, LLC | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −25,403−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −22,477−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −22,020−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −11,602−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,903−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −8,209−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,412−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −475−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |